Eevia Health

Eevia Health

Eevia Health Partners with Canadian Nutraceutical Leader image

Eevia Health Partners with Canadian Nutraceutical Leader

Sammanfattning

Eevia Health partners with a Canadian nutraceutical leader to boost global sales of its innovative FENO-SAMBUCUS™ 30 extract, enhancing its market reach and sustainability credentials.
Eevia Health has announced a strategic partnership with a leading Canadian nutraceutical company, marking a significant milestone in its global expansion strategy.

Eevia Health, the innovative Finnish company known for its high-quality plant-based extracts, has taken a significant step forward in its global expansion strategy. The company recently announced a strategic partnership with a prominent Canadian nutraceutical player, a subsidiary of a multinational group. This collaboration aims to leverage the Canadian partner's extensive market reach and premium marketing capabilities to drive sales of Eevia's flagship product, FENO-SAMBUCUS™ 30, to new heights.

The relaunch of FENO-SAMBUCUS™ 30 earlier this year caught the attention of the Canadian company, thanks to its unique position in the market as a high-strength, excipient-free elderberry extract. With twice the amount of key bioactives compared to other products, FENO-SAMBUCUS™ 30 offers significant operational benefits for manufacturers, including reduced dosage volume and potential cost savings per dose.

Manufactured at Eevia's state-of-the-art green-chemistry facility in Finland, FENO-SAMBUCUS™ 30 is produced from European Elderberries and boasts a remarkable 30% anthocyanins and 50% total polyphenols. The product is not only potent but also sustainable, with a low carbon footprint and nearly sugar-free composition, setting a new benchmark for purity in the industry.

The partnership with the Canadian nutraceutical leader is a strategic move for Eevia Health, enabling the company to expand its footprint in the global market. The initial order of KEUR 70 signifies a promising start to this collaboration, which aligns with Eevia's mission to offer high-impact, science-backed health solutions worldwide.

From an investment perspective, this partnership positions Eevia Health as a strong contender in the nutraceutical sector, with potential for significant growth. The company's commitment to sustainability and innovation, combined with the marketing prowess of its new partner, suggests a promising future. Investors may want to consider this development as a positive indicator of Eevia's continued success and market expansion.

Relaterade nyheter

Loading...